Key result
Delayed presentation in suspected PE shows no difference in recurrent VTE rates versus early presentation.
Why the study?
The nonspecific clinical presentation of pulmonary embolism frequently leads to delay in its diagnosis, and the impact of this delay on diagnostic management and clinical outcome was unclear.
Does delayed clinical presentation affect the safety of excluding pulmonary embolism using a clinical decision rule and D-dimer testing in patients with suspected pulmonary embolism?
Cohort (n=4,044)
Does delayed clinical presentation affect the safety of excluding pulmonary embolism using a clinical decision rule and D-dimer testing in patients with suspected pulmonary embolism?
A clinical decision rule combined with D-dimer testing can safely exclude pulmonary embolism regardless of whether the patient has a delayed clinical presentation (>7 days).
Answers are grounded in this paper and cite their sources.
Supports safe PE exclusion by CDR plus D-dimer despite diagnostic delay; extends evidence but leaves open need for prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Exter et al. (2013) conducted a cohort in suspected pulmonary embolism (n=4,044). Delayed presentation (>7 days from symptom onset) vs. Presentation within 7 days was evaluated on recurrent venous thromboembolism (p=0.14). Delayed presentation (>7 days) in suspected pulmonary embolism did not affect the 3-month rate of recurrent venous thromboembolism compared to earlier presentation.
Synapse has enriched 10 related papers. Consider them for comparative context: